© 2019 BIOINICIA

Webinar_BioPharma_Bioinicia_Janssen Pharmaceutical

Book your seat for the webinar: New drying processes for biopharmaceuticals

Book your seat for the webinar: New drying processes for biopharmaceuticals

Date: 5th May 2020

Time: 10.00 am EST,  16:00 CET

The webinar “New drying processes for biopharmaceuticals” will take place May, 5th 2020 at 10.00 am (EST) being presented by Sune Klint Andersen, Principal Scientist at Janssen Pharmaceutical Companies of Johnson & Johnson and followed by Lars Markwort, co-founder and CEO of Bioinicia.

In this webinar, the presenters will be speaking on particle engineering, drying kinetics, aseptic spray drying and the advantages and disadvantages of spray vs freeze drying processes as well as the scaling up of electrohydrodynamic processes (electrospinning and electrospraying) to industrial production with a focus on drying, micronization and encapsulating of labile bioactives for applications in pharmaceuticals and nutraceuticals.

Sune Klint Andersen, Principal Scientist at Janssen Pharmaceutical Companies of Johnson & Johnson

Sune-Klint-AndersenSune Klint Andersen is Principal Scientist for Spray Drying at the Janssen Pharmaceutical Companies of Johnson & Johnson. He has a Ph.D. in Chemical Engineering. He has worked with pharmaceutical spray drying for 17 years within process development for R&D and commercial scale, application of Quality-by-Design and PAT, particle engineering, drying kinetics, aseptic spray drying and advantages and disadvantages of spray vs freeze drying processes. He previously worked at Novo Nordisk for 7 years.

 

Lars Markwort, Co-founder and CEO of  Bioinicia

Lars-Markwort-BioiniciaLars Markwort is co-founder and CEO of Bioinicia SL. He holds a Ph.D. in Chemistry and worked for 20 years in the analytical and process equipment industry, supplying mainly the semiconductor and pharmaceutical industries. At Bioinicia he is guiding the scaling up of electrohydrodynamic processes to industrial production with a focus on drying, micronization and encapsulating of labile bioactives for applications in pharmaceuticals and nutraceuticals.

 

Electrohydrodynamic Processing for Drying, Micronization and Encapsulation of Labile Bioactives

Lars Markwort will show how electrohydrodynamic processing, commonly known as electrospinning and electrospraying, is used to simultaneously dry and encapsulate labile bioactives. Bioactives are processed from solution, emulsion or suspension into nano- and micro-structured fibres and particles. The process can be run at room temperature and below and is sufficiently mild, that processing of live microorganisms, i.e. probiotics is possible. As a beneficial side-effect, poorly soluble crystalline active pharmaceutical ingredients (API) can be processed into amorphous solid solutions or dispersions with significantly improved solubility and bioactivity. Finally, he will explain how electrohydrodynamic processing offers great flexibility to reformulate API into many different delivery forms, ranging from fibrous nonwovens in transmucosal patches to encapsulated particles for improved oral tablets and injectables.

Sponsored by Bioinicia

Bioinicia_logo

Bioinicia is a specialty contract development and manufacturing company dedicated nano and microstructured materials for applications in pharmaceuticals, nutraceuticals, cosmetics and biomedical devices. Bioinicia also develops and commercializes premium quality electrospinning equipment for laboratory to industrial-scale processing.

Do not miss the chance and register today here!

https://biopharma-asia.com/webinars/new-drying-processes-for-biopharmaceuticals/

 

No Comments

Post A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.